Piracetam Injection
- Packing: 15 Ml Ampoule, 60 Ml Vial
- Available Strength : 200 Mg/Ml
Description
Product Description: Piracetam Injection is a meticulously formulated pharmaceutical solution designed to enhance cognitive function and improve memory. It contains piracetam, a nootropic agent known for its neuroprotective and cognitive-enhancing effects. Manufactured to the highest quality standards, this injection offers fast-acting cognitive support for patients with cognitive impairment or neurological disorders.
Indications and Usage: Piracetam Injection is indicated for the treatment of cognitive disorders and memory deficits associated with various neurological conditions, such as dementia, Alzheimer's disease, and post-stroke cognitive impairment. It is particularly useful in situations where rapid onset of action and intravenous administration are necessary for optimal therapeutic outcomes.
Dosage and Administration: The dosage of Piracetam Injection varies depending on the patient's age, weight, and the severity of cognitive impairment. It is typically administered via intravenous infusion or injection under the supervision of a qualified healthcare professional. The dosage regimen may involve loading doses followed by maintenance infusions, as determined by the treating physician.
Dosage Forms and Strengths: Piracetam Injection is available as a sterile solution in vials containing specific concentrations of piracetam formulated for parenteral administration. Each vial is carefully manufactured to ensure accurate dosing and optimal therapeutic outcomes.
Contraindications: This product is contraindicated in patients with a known hypersensitivity to piracetam or any of the excipients. It should not be used in patients with severe renal impairment or in those with a history of hemorrhagic stroke. Additionally, it is contraindicated in pregnant women, particularly during the first trimester.
Warnings and Precautions: Healthcare providers should exercise caution when prescribing Piracetam Injection to patients with a history of bleeding disorders or renal dysfunction. Rarely, serious adverse effects such as thrombocytopenia, hemorrhage, or hypersensitivity reactions may occur. Patients should be monitored closely for signs of these adverse effects during therapy.
Adverse Reactions/Side Effects: Common adverse reactions associated with Piracetam Injection include headache, dizziness, and gastrointestinal disturbances. Rarely, serious adverse effects such as allergic reactions, thrombocytopenia, or hemorrhage may occur. Patients should be advised to report any unusual symptoms promptly.
Drug Interactions: Concomitant use of Piracetam Injection with other anticoagulant or antiplatelet agents may increase the risk of bleeding or potentiate the effects of piracetam. Healthcare providers should review the patient's medication profile carefully to avoid potential drug interactions.
Use In Specific Populations Description: Safety and efficacy of Piracetam Injection in pediatric patients, pregnant women, and nursing mothers have not been established conclusively. Healthcare providers should assess the potential risks and benefits before prescribing this medication in these populations.
How Supplied/Storage and Handling: Piracetam Injection is supplied as a sterile solution in vials for parenteral administration. It should be stored at controlled room temperature away from light and moisture. Care should be taken to avoid freezing or excessive heat exposure. Unused portions should be discarded according to standard procedures for biohazardous waste.